Upcoming Meetings: FDA's Blood Products Advisory Committee
This article was originally published in The Gray Sheet
FDA's Blood Products Advisory Committee: Will meet June 23 at 8 a.m. at the Marriott in Bethesda, Maryland, according to a May 24 Federal Register notice. The committee will discuss and provide recommendations on HIV antigen screening of blood donors, as well as review "the report of the intramural research site visit of the Laboratory of Cellular Hematology" at the Center for Biologics Evaluation and Research. For more information call FDA's advisory committee information hotline: 800/741-8138 or 301/443-0572, or Linda Smallwood at CBER, 301/594-6700...
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.